Literature DB >> 33257199

Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature.

Jawad Ahmad1, Joseph A Odin1, Paul H Hayashi2, Robert J Fontana3, Hari Conjeevaram3, Bharathi Avula4, Ikhlas A Khan4, Huiman Barnhart5, Raj Vuppalanchi6, Victor J Navarro7.   

Abstract

BACKGROUND: Kratom is a botanical product used as an opium substitute with abuse potential.
METHODS: Assessment of suspected cases of kratom-induced liver injury in a prospective US cohort.
RESULTS: Eleven cases of liver injury attributed to kratom were identified with a recent increase. The majority were male with median age 40 years. All were symptomatic and developed jaundice with a median latency of 14 days. The liver injury pattern was variable, most required hospitalization and all eventually recovered. Biochemical analysis revealed active kratom ingredients.
CONCLUSION: Kratom can cause severe liver injury with jaundice.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  7-hydroxymitragynine; Hepatotoxicity; Kratom; Mitragynine; Opioid

Mesh:

Substances:

Year:  2020        PMID: 33257199      PMCID: PMC8113016          DOI: 10.1016/j.drugalcdep.2020.108426

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  11 in total

1.  Kratom as a substitute for opioids: Results from an online survey.

Authors:  Marion A Coe; Janine L Pillitteri; Mark A Sembower; Karen K Gerlach; Jack E Henningfield
Journal:  Drug Alcohol Depend       Date:  2019-06-29       Impact factor: 4.492

2.  HLA-B*35:01 Allele Is a Potential Biomarker for Predicting Polygonum multiflorum-Induced Liver Injury in Humans.

Authors:  Chaopeng Li; Tai Rao; Xiaoping Chen; Zhengsheng Zou; Aiwu Wei; Jinfa Tang; Peng Xiong; Pengyan Li; Jing Jing; Tingting He; Zhaofang Bai; Jiye Yin; Zhirong Tan; Peng Yu; Honghao Zhou; Jiabo Wang; Xiaohe Xiao; Dongsheng Ouyang
Journal:  Hepatology       Date:  2019-05-21       Impact factor: 17.425

3.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Authors:  Naga Chalasani; Herbert L Bonkovsky; Robert Fontana; William Lee; Andrew Stolz; Jayant Talwalkar; K Rajendar Reddy; Paul B Watkins; Victor Navarro; Huiman Barnhart; Jiezhun Gu; Jose Serrano
Journal:  Gastroenterology       Date:  2015-03-06       Impact factor: 22.682

Review 4.  From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction.

Authors:  Zurina Hassan; Mustapha Muzaimi; Visweswaran Navaratnam; Nurul H M Yusoff; Farah W Suhaimi; Rajakumar Vadivelu; Balasingam K Vicknasingam; Davide Amato; Stephan von Hörsten; Nurul I W Ismail; Nanthini Jayabalan; Ammar I Hazim; Sharif M Mansor; Christian P Müller
Journal:  Neurosci Biobehav Rev       Date:  2012-12-01       Impact factor: 8.989

5.  Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.

Authors:  Robert J Fontana; Paul B Watkins; Herbert L Bonkovsky; Naga Chalasani; Timothy Davern; Jose Serrano; James Rochon
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.

Authors:  Paola Nicoletti; Guruprasad P Aithal; Einar S Bjornsson; Raul J Andrade; Ashley Sawle; Marco Arrese; Huiman X Barnhart; Emmanuelle Bondon-Guitton; Paul H Hayashi; Fernando Bessone; Alfonso Carvajal; Ingolf Cascorbi; Elizabeth T Cirulli; Naga Chalasani; Anita Conforti; Sally A Coulthard; Mark J Daly; Christopher P Day; John F Dillon; Robert J Fontana; Jane I Grove; Pär Hallberg; Nelia Hernández; Luisa Ibáñez; Gerd A Kullak-Ublick; Tarja Laitinen; Dominique Larrey; M Isabel Lucena; Anke H Maitland-van der Zee; Jennifer H Martin; Mariam Molokhia; Munir Pirmohamed; Elizabeth E Powell; Shengying Qin; Jose Serrano; Camilla Stephens; Andrew Stolz; Mia Wadelius; Paul B Watkins; Aris Floratos; Yufeng Shen; Matthew R Nelson; Thomas J Urban; Ann K Daly
Journal:  Gastroenterology       Date:  2016-12-30       Impact factor: 22.682

Review 7.  Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review.

Authors:  Jonathan Schimmel; Richard C Dart
Journal:  Drugs       Date:  2020-02       Impact factor: 11.431

8.  Notes from the Field: Unintentional Drug Overdose Deaths with Kratom Detected - 27 States, July 2016-December 2017.

Authors:  Emily O'Malley Olsen; Julie O'Donnell; Christine L Mattson; Joshua G Schier; Nana Wilson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-04-12       Impact factor: 17.586

9.  Evaluating kratom alkaloids using PHASE.

Authors:  Christopher R Ellis; Rebecca Racz; Naomi L Kruhlak; Marlene T Kim; Alexey V Zakharov; Noel Southall; Edward G Hawkins; Keith Burkhart; David G Strauss; Lidiya Stavitskaya
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

10.  A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.

Authors:  Elizabeth T Cirulli; Paola Nicoletti; Karen Abramson; Raul J Andrade; Einar S Bjornsson; Naga Chalasani; Robert J Fontana; Pär Hallberg; Yi Ju Li; M Isabel Lucena; Nanye Long; Mariam Molokhia; Matthew R Nelson; Joseph A Odin; Munir Pirmohamed; Thorunn Rafnar; Jose Serrano; Kári Stefánsson; Andrew Stolz; Ann K Daly; Guruprasad P Aithal; Paul B Watkins
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

View more
  2 in total

Review 1.  Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review.

Authors:  Catherine W Striley; Carolin C Hoeflich; Andrew T Viegas; Lindsey A Berkowitz; Emily G Matthews; Leyla P Akin; Chidinma Iheanyi-Okeahialam; Urmeen Mansoor; Christopher R McCurdy
Journal:  Subst Abuse       Date:  2022-05-20

2.  Kratom-Induced Liver Injury: A Case Series and Clinical Implications.

Authors:  Mahesh Botejue; Gurjot Walia; Omar Shahin; Jyotsna Sharma; Rasiq Zackria
Journal:  Cureus       Date:  2021-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.